Literature DB >> 11103750

Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers.

D I Min1, M Lee, Y M Ku, M Flanigan.   

Abstract

Pharmacokinetic studies of intravenous and oral cyclosporine (cyclosporin) were performed in 22 healthy African American (n = 11) and white (n = 11) volunteers. Blood cyclosporine concentrations were measured by high performance liquid chromatography. Concentration versus time data were analyzed by noncompartmental models, and statistical analyses were performed by ANOVA. The clearance of intravenous and oral cyclosporine was 4.3 +/- 0.9 mL/min/kg and 13.5 +/- 4.5 mL/min/kg, respectively, in African Americans and 3.7 +/- 0.5 mL/min/kg and 9.6 mL/min/kg, respectively, in the white volunteers (P = .0001). There was a significant race and gender interaction (P = .038). Bioavailability was lower in African Americans (32.8 +/- 6.6%) compared with white volunteers (39.3 +/- 7.1%; P = .049), with a significant race and gender interaction (P = .048). The dose-adjusted area under the curve (AUC) of intravenous and oral cyclosporine was 54.3 +/- 10.6 ng x hr/mL per milligram and 18.1 +/- 4.1 ng x hr/mL per milligram, respectively, in African Americans and 61.9 +/- 6.8 ng x hr/mL per milligram and 24.2 +/- 4.6 ng x hr/mL per milligram, respectively, in white volunteers (P = .023). These findings suggest that disposition of cyclosporine is dependent both on race and on gender.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103750     DOI: 10.1067/mcp.2000.111255

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  Ethnic disparities in liver transplantation.

Authors:  Nyingi Kemmer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

2.  Prediction of biogeographical ancestry from genotype: a comparison of classifiers.

Authors:  Elaine Y Y Cheung; Michelle Elizabeth Gahan; Dennis McNevin
Journal:  Int J Legal Med       Date:  2016-12-20       Impact factor: 2.686

3.  Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.

Authors:  Stéphane Mouly; Nathalie Rizzo-Padoin; Guy Simoneau; Céline Verstuyft; Guy Aymard; Cécile Salvat; Isabelle Mahé; Jean-François Bergmann
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

Review 4.  Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and Efficacy.

Authors:  Joyce Oi Yan Chan; Marie Moullet; Beth Williamson; Rosalinda H Arends; Venkatesh Pilla Reddy
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

5.  A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.

Authors:  Kenneth W Renton; John F S Crocker; Heather McLellan; Philip D Acott
Journal:  Eur J Clin Pharmacol       Date:  2004-07-01       Impact factor: 2.953

6.  Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.

Authors:  Dorothée Fruit; Annick Rousseau; Catherine Amrein; Florence Rollé; Nassim Kamar; Laurent Sebbag; Michel Redonnet; Eric Epailly; Pierre Marquet; Aurélie Prémaud
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

7.  External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.

Authors:  Jun-Jun Mao; Zheng Jiao; Hwi-Yeol Yun; Chen-Yan Zhao; Han-Chao Chen; Xiao-Yan Qiu; Ming-Kang Zhong
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

8.  Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential.

Authors:  Michael Gertz; Catherine M Cartwright; Michael J Hobbs; Kathryn E Kenworthy; Malcolm Rowland; J Brian Houston; Aleksandra Galetin
Journal:  Pharm Res       Date:  2012-11-22       Impact factor: 4.200

9.  Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.

Authors:  Karl Henrik Johannes Ehinger; Magnus Joakim Hansson; Fredrik Sjövall; Eskil Elmér
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

10.  Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.

Authors:  Rocco C Venuto; Calvin J Meaney; Shirley Chang; Nicolae Leca; Joseph D Consiglio; Gregory E Wilding; Daniel Brazeau; Aijaz Gundroo; Neha Nainani; Sarah E Morse; Louise M Cooper; Kathleen M Tornatore
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.